November, 2023

Categories:development course
Author:InnoModels
Origin:InnoModels
Time of issue:2023-11-03 15:53
Views:

(Summary description)Accredited by AAALAC

November, 2023

(Summary description)Accredited by AAALAC

Categories:development course
Author:InnoModels
Origin:InnoModels
Time of issue:2023-11-03 15:53
Views:

Information

Accredited by AAALAC

Previous: None

Next: September, 2023

Previous: None

Next: September, 2023

3D Organoid Platform of InnoModels Biotechnology: Opening a New Chapter in Life Science [ 2024-10-14 ]

In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms

PDX in vivo efficacy model of InnoModels Biotechnology [ 2024-10-11 ]

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.

InnoModels' CDX Modeling Platform: An Innovative Force for Cancer Research and Drug Development [ 2024-10-10 ]

In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.

In Vitro Killing Experiment Platform of InnoModels Biotechnology [ 2024-10-09 ]

In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.

Introduction to the in vivo tumor experimental platform of InnoModels Biotechnology [ 2024-10-08 ]

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic

In Vitro Killing Experimental Platform from InnoModels Biotechnology [ 2024-09-25 ]

In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.

…

Tel 15010000264
After sales
Tel 13810723384
Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL：15010000264 13810723384

Email：cndw@imodels.tec

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company